Hormone problems and hair loss are closely linked, with imbalances in androgens, thyroid hormones, oestrogen, and cortisol all capable of disrupting the hair growth cycle. Conditions such as polycystic ovary syndrome (PCOS), hypothyroidism, and menopause are among the most common hormonal causes of thinning or excessive shedding in the UK. Understanding which hormones are involved — and why — is the first step towards an accurate diagnosis and effective treatment. This article explains the key hormonal mechanisms, the medical conditions most often responsible, how to access NHS investigation and specialist care, and what treatment options are available.

How Hormonal Imbalances Cause Hair Loss

Hormonal imbalances disrupt the hair growth cycle by causing follicle miniaturisation, premature entry into the resting phase, or slowed regrowth — with androgens, oestrogen, thyroid hormones, and cortisol all playing roles.

Hair growth follows a carefully regulated cycle consisting of three phases: anagen (active growth), catagen (transition), and telogen (resting and shedding). Hormones play a central role in governing this cycle, and when hormone levels fall out of balance, the cycle can be disrupted — leading to excessive shedding, thinning, or slowed regrowth.

Androgens, including testosterone and its more potent derivative dihydrotestosterone (DHT), are among the most well-studied hormones in relation to hair loss. In individuals who are genetically predisposed, DHT binds to receptors in hair follicles and causes them to miniaturise over time — a process known as androgenetic alopecia. Importantly, this condition reflects the genetic sensitivity of hair follicles to androgens, rather than necessarily indicating abnormally high androgen levels. However, androgens are not the only hormones involved. Thyroid hormones, oestrogen, progesterone, cortisol, and insulin all interact with hair follicle biology in meaningful ways.

Not sure if this is normal? Chat with one of our pharmacists →

Oestrogen is generally considered protective for hair growth, which is why many women notice significant shedding after childbirth or during the menopause — periods when oestrogen levels drop sharply. Physical or psychological stress, significant illness, and major surgery can also push a large number of follicles prematurely into the telogen phase, resulting in a condition called telogen effluvium. Cortisol is one of several mediators involved in this process, though the precise mechanism is not fully established. This type of hair loss is typically diffuse rather than patterned, and may not become apparent until two to three months after the trigger. Postpartum telogen effluvium, for example, commonly begins two to three months after delivery and usually resolves over six to twelve months without treatment.

Understanding the underlying hormonal mechanism is essential for guiding appropriate investigation and treatment, as different causes require very different approaches.

Common Hormonal Conditions Linked to Hair Thinning

PCOS, thyroid disorders, and menopause are the most common hormonal conditions causing hair thinning; each has distinct diagnostic criteria and requires targeted management.

Several well-recognised medical conditions involving hormonal dysregulation are associated with hair loss. Identifying the underlying condition is a critical first step towards effective management.

Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders in women of reproductive age, affecting approximately 1 in 10 women in the UK. Elevated androgen levels in PCOS can cause hair thinning at the crown and temples — a pattern similar to male-pattern baldness — alongside other symptoms such as irregular periods, acne, and weight gain. When PCOS is suspected, androgen testing (total testosterone and sex hormone-binding globulin, used to calculate the free androgen index) is more informative than LH/FSH ratios, which are no longer considered diagnostic.

Thyroid disorders — both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) — are strongly linked to diffuse hair thinning. The thyroid gland regulates metabolism throughout the body, including within hair follicles. Thyroid function testing is appropriate when there are clinical features suggesting thyroid disease, such as fatigue, weight change, cold intolerance, or palpitations, rather than as a routine test for all hair loss.

Menopause and perimenopause bring a natural decline in oestrogen and progesterone, which can unmask or accelerate androgenetic alopecia in women who are genetically susceptible. This is increasingly recognised as a significant quality-of-life concern.

Other relevant conditions include:

• Adrenal disorders, such as Cushing's syndrome, which cause excess cortisol

• Hyperprolactinaemia, where elevated prolactin levels may suppress sex hormones; the direct link to scalp hair thinning is plausible but based on limited evidence

• Type 2 diabetes and insulin resistance, which may indirectly affect androgen metabolism; evidence for a direct effect on scalp hair is observational

• Postpartum hormonal shifts, which commonly trigger temporary telogen effluvium that usually resolves without treatment

Each of these conditions has distinct diagnostic criteria and management pathways, reinforcing the importance of a thorough clinical assessment rather than self-diagnosis.

Getting a Diagnosis: Tests and NHS Referral Pathways

Start with your GP, who will take a history, examine the scalp, and request targeted blood tests such as TSH, serum ferritin, and testosterone/SHBG; specialist referral depends on findings.

If you are concerned about hair loss that may be hormone-related, your first point of contact should be your GP. A thorough consultation will typically include a detailed medical history, a review of any medications you are taking, and a physical examination of the scalp and hair pattern. This initial assessment helps distinguish between different types of alopecia and guides appropriate investigation. Tests are tailored to the clinical picture rather than ordered as a blanket panel.

Have questions about your medication? Our pharmacists are here to help →

Depending on your symptoms and examination findings, your GP may request some of the following blood tests:

• Full blood count — to rule out anaemia, which can itself cause shedding

• Thyroid function tests — in UK practice, TSH is measured first; free T4 is added if TSH is abnormal; free T3 is reserved for selected cases of suspected hyperthyroidism

• Serum ferritin — iron stores are closely linked to hair health

• Hormone profile — when hyperandrogenism is suspected (e.g., in PCOS), total testosterone and SHBG are requested to calculate the free androgen index; LH and FSH may be checked in specific circumstances but are not diagnostic for PCOS

• Prolactin — if hyperprolactinaemia is suspected

• HbA1c or fasting glucose — to assess for insulin resistance or diabetes

• Cortisol — if adrenal dysfunction is clinically suspected

When to seek urgent assessment: Certain features warrant prompt referral rather than routine investigation. Contact your GP urgently if you notice signs of virilisation (rapid-onset excessive facial or body hair, voice deepening, or other masculinising changes), as these may indicate a significant androgen excess requiring urgent evaluation. Features suggesting scarring alopecia — such as scalp pain, persistent redness, scaling, or loss of visible follicular openings — also require prompt dermatology review, as scarring forms of hair loss can cause permanent follicle damage if not treated early.

Depending on the findings, your GP may refer you to a relevant specialist. Women with suspected PCOS may be referred to an endocrinologist or gynaecologist. Those with confirmed thyroid disease will typically be managed in primary care, though complex cases may warrant endocrinology input. For hair loss without a clear hormonal cause, or where the diagnosis is uncertain, referral to a consultant dermatologist is appropriate. Some NHS trusts have specialist hair loss clinics, which are dermatology-led services; availability varies by region.

Waiting times on the NHS can be lengthy, and some patients choose to pursue private consultations to access specialist assessment more quickly.

Treatment Options for Hormone-Related Hair Loss in the UK

Treatment is directed at the underlying hormonal cause; options include levothyroxine, combined oral contraceptives, spironolactone, and topical minoxidil, each with specific licensing and safety considerations.

Treatment for hormone-related hair loss depends entirely on the underlying cause. Addressing the root hormonal imbalance is the most effective long-term strategy, and in many cases, hair regrowth follows successful treatment of the primary condition.

For thyroid-related hair loss, levothyroxine (for hypothyroidism) or antithyroid medications such as carbimazole (for hyperthyroidism) are the mainstay of treatment. Hair regrowth typically occurs gradually over several months once thyroid levels are stabilised.

For PCOS-related hair loss, management may include:

• Combined oral contraceptives (COCs) — some COCs contain progestogens with anti-androgenic properties (such as drospirenone or cyproterone acetate). Co-cyprindiol (containing cyproterone acetate) and these COCs are not licensed specifically for hair loss; they are used for other androgen-related indications such as acne or hirsutism. All COCs carry a risk of venous thromboembolism (VTE), which varies by formulation. The MHRA has also issued a safety warning that cyproterone acetate is associated with a small increased risk of meningioma, particularly at higher cumulative doses; this should be discussed with your prescriber.

• Spironolactone — an aldosterone antagonist with anti-androgenic properties, used off-label for androgen-related hair loss in women. It is not licensed for this indication in the UK. Women of childbearing potential must use effective contraception whilst taking spironolactone, as there is a theoretical risk of feminisation of a male foetus. Potassium levels and renal function should be checked at baseline and after dose changes. Initiation should be under clinician supervision.

• Metformin — may help manage insulin resistance associated with PCOS, which can have indirect benefits; however, evidence that metformin directly improves scalp hair is limited.

For androgenetic alopecia, topical minoxidil (available over the counter) is licensed for use in both men and women and remains one of the most evidence-based treatments available. It works by prolonging the anagen phase and increasing follicle size. Treatment must be continued to maintain benefit; stopping minoxidil typically leads to renewed shedding within months. Common local side effects include scalp irritation and, in some women, unwanted facial hair if the product contacts the face. Finasteride, a 5-alpha reductase inhibitor that reduces DHT production, is licensed for men in the UK but is not licensed for women. It is strictly contraindicated in women who are or may become pregnant due to teratogenic risk. Men should be aware that finasteride can cause sexual dysfunction and mood changes in some individuals.

Hormone replacement therapy (HRT) may benefit perimenopausal and postmenopausal women experiencing hair thinning, though evidence that HRT directly improves scalp hair is limited and it is not licensed for this indication. NICE guidance on menopause (NG23) supports the use of HRT for quality-of-life symptoms, and hair may improve as a secondary benefit in some women. All treatment decisions should be made in partnership with a qualified clinician.

If you experience a suspected side effect from any medication, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Lifestyle Changes That May Support Hair Regrowth

Correcting nutritional deficiencies, managing stress, and gentle scalp care can support hair regrowth alongside medical treatment, but are not a substitute for addressing the underlying hormonal cause.

Whilst medical treatment addresses the underlying hormonal cause, certain lifestyle modifications can create a more favourable environment for hair regrowth and may help slow further loss. These measures are supportive rather than curative, and should complement — not replace — appropriate clinical care.

Nutrition plays an important role in hair follicle health. Deficiencies in iron, zinc, vitamin D, and B vitamins — including B12 — have been associated with hair thinning in observational studies. A balanced diet rich in lean proteins, leafy green vegetables, nuts, seeds, and oily fish provides many of the micronutrients that follicles require. It is advisable to confirm a deficiency through blood tests before starting supplements, as supplementing without a confirmed deficiency has limited evidence for reversing hair loss, and excess intake of certain nutrients can cause harm. High-dose vitamin A, for example, can paradoxically worsen hair loss. If you are taking biotin (vitamin B7) supplements, be aware that biotin can interfere with a range of laboratory immunoassays — including thyroid function tests and cardiac troponin — and may produce falsely abnormal results. Discuss the timing of any supplements with your clinician or the laboratory before blood tests are taken.

Stress management is particularly relevant given the role of physical and psychological stress in triggering telogen effluvium. Techniques such as mindfulness-based stress reduction (MBSR), regular physical activity, adequate sleep, and cognitive behavioural therapy (CBT) may help regulate the stress response over time.

Scalp care should not be overlooked. Gentle handling of hair — avoiding excessive heat styling, tight hairstyles, and harsh chemical treatments — reduces mechanical stress on already vulnerable follicles. There is no strong clinical evidence that specific shampoos or scalp massages reverse hormone-related hair loss, though maintaining a clean, healthy scalp environment is generally beneficial.

Maintaining a healthy body weight is particularly relevant in PCOS, where weight loss of even 5–10% of body weight has been shown to improve androgen levels and menstrual regularity, which may in turn benefit hair health.

When to See Your GP About Hair Loss and Hormones

See your GP promptly if hair loss is sudden, diffuse, or accompanied by symptoms such as fatigue, irregular periods, or weight changes; seek urgent advice if virilisation or scarring alopecia features are present.

Many people experience some degree of hair shedding at various points in their lives, and not all hair loss requires urgent medical attention. However, there are specific circumstances in which it is important to seek a GP assessment promptly, particularly when a hormonal problem may be the underlying cause.

Seek urgent medical advice if you notice:

• Signs of virilisation — such as rapid-onset excessive facial or body hair, deepening of the voice, or other masculinising changes — as these may indicate significant androgen excess requiring prompt investigation

• Features that may suggest scarring alopecia, including scalp pain, persistent redness, scaling, or areas where follicular openings are no longer visible; scarring forms of hair loss can cause permanent damage if not treated early and warrant prompt dermatology review

Contact your GP if you notice:

• Sudden or rapid hair loss over a short period

• Diffuse thinning across the entire scalp rather than a gradual recession

• Hair loss accompanied by other symptoms such as unexplained weight changes, fatigue, irregular periods, acne, or mood disturbances — all of which may suggest an underlying hormonal condition

• Patchy hair loss, which may indicate alopecia areata — an autoimmune condition that, whilst not directly hormonal, can co-occur with thyroid disease

• Hair loss that is causing significant psychological distress, as this in itself warrants clinical support

• No improvement after several months of over-the-counter treatment

If you have recently experienced a major illness, surgery, or childbirth and notice diffuse shedding, this is often telogen effluvium and tends to be self-limiting. However, seek a review if shedding is severe, prolonged beyond six to twelve months, or accompanied by other symptoms.

It is also worth seeking advice if you have recently started or stopped a hormonal medication — such as the contraceptive pill, HRT, or corticosteroids — as these can all influence hair cycling. Similarly, if you have a known hormonal condition such as PCOS or thyroid disease and notice a change in your hair, inform your healthcare team so that your management plan can be reviewed.

Early assessment is valuable because some causes of hormone-related hair loss are highly treatable, and the sooner the underlying imbalance is identified and addressed, the better the prospects for hair recovery. Your GP can provide reassurance, arrange appropriate investigations, and refer you to the right specialist if needed.

Frequently Asked Questions